Komori
Revision to earnings forecasts4548SEIKAGAKU CORPORATIONPharmaceuticals

Notice Regarding Revisions to Full-Year Consolidated Financial Forecasts for the Fiscal Year Ending March 2027

For the full year ending March 2027, the consolidated revenue forecast was left unchanged at ¥37,100 million, while the operating loss forecast was revised from ¥2,050 million to ¥2,900 million, the ordinary profit forecast from ¥200 million to an ordinary loss of ¥650 million, and the net loss attributable to owners of the parent from ¥1,800 million to ¥2,700 million. The main reason was an increase in R&D expenses associated with preparations for the resubmission of SI-6603. The dividend forecast remains unchanged.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-850
Millions of yen
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Full yearPrevious forecast published 24 September 2026
Net Sales37,100→37,100Millions of yen
0.0%
Operating profit-2,050→-2,900Millions of yen
-41.5%
Ordinary income200→-650Millions of yen
-425.0%
Profit attributable to owners of the parent-1,800→-2,700Millions of yen
-50.0%
Net income per share-32.96→-49.43Yen
-50.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

Revenue is unchanged from the previous announcement, while operating profit is expected to decrease by ¥850 million, mainly due to higher R&D expenses associated with preparations for the resubmission of SI-6603. As a result, ordinary profit is expected to be an ordinary loss of ¥650 million and net income attributable to owners of the parent is expected to be a net loss of ¥2,700 million.

Previous-period resultsPrior-year consolidated results (fiscal year ended March 2026): revenue ¥36,645 million, operating loss ¥660 million, ordinary profit ¥1,679 million, net income attributable to owners of the parent ¥1,473 million, and basic earnings per share ¥26.99
Dividend forecast revisionNo revision (the dividend forecast has not been changed in connection with this revision to the earnings forecast)
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales37,100 Millions of yen → 37,100 Millions of yen
Operating profit-2,050 Millions of yen → -2,900 Millions of yen
Ordinary income200 Millions of yen → -650 Millions of yen
Profit attributable to owners of the parent-1,800 Millions of yen → -2,700 Millions of yen
Net income per share-32.96 Yen → -49.43 Yen
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredFull year
Publication date of previous forecast24 September 2026
Previous-period resultsPrior-year consolidated results (fiscal year ended March 2026): revenue ¥36,645 million, operating loss ¥660 million, ordinary profit ¥1,679 million, net income attributable to owners of the parent ¥1,473 million, and basic earnings per share ¥26.99
Reason for the revisionRevenue is unchanged from the previous announcement, while operating profit is expected to decrease by ¥850 million, mainly due to higher R&D expenses associated with preparations for the resubmission of SI-6603. As a result, ordinary profit is expected to be an ordinary loss of ¥650 million and net income attributable to owners of the parent is expected to be a net loss of ¥2,700 million.
Dividend forecast revisionNo revision (the dividend forecast has not been changed in connection with this revision to the earnings forecast)
Consolidated / non-consolidatedConsolidated
Items this document does not state (1)
Details and amount of extraordinary loss

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The outlook calls for operating profit to decrease by ¥850 million from the previous forecast due to higher R&D expenses associated with preparations for the resubmission of SI-6603.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Revisions to Full-Year Consolidated Financial Forecasts for the Fiscal Year Ending March 2027 | SEIKAGAKU CORPORATION (4548) timely disclosure | Komori